Abstract
Assessment of bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA) plays a vital role in the diagnosis of osteoporosis and in monitoring a patient's response to drug therapy. This commentary will discuss controversies surrounding the use of DXA for screening and monitoring of BMD in women.
- ©2014 by the North Carolina Institute of Medicine and The Duke Endowment. All rights reserved.
In this issue
Dual-Energy X-Ray Absorptiometry
INVITED COMMENTARIES AND SIDEBARS